Marc joined AstraZeneca in June 2013 as Executive Vice-President, Global Portfolio & Product Strategy before being appointed as an Executive Director and Chief Financial Officer in November 2013. Marc qualified as an accountant and joined AstraZeneca in 2013, serving as Executive VicePresident, GPPS from June to October 2013. June 4 (Reuters) - AstraZeneca will move finance chief Marc Dunoyer to head newly acquired rare diseases business Alexion , using the $39 billion takeover as an opportunity to freshen up a . AstraZeneca agreed to buy Alexion in December in its largest ever deal, a bet on rare-disease immunology which also includes a fast-growing cancer medicines unit and a major COVID-19 vaccine. Dunoyer will become the U.S. drugmaker's chief executive officer. In November 2013, he was appointed as an Executive Director and Chief Financial Officer. Marc joined AstraZeneca in June 2013 as Executive Vice-President, Global Portfolio & Product Strategy before being appointed as an Executive Director and Chief Financial Officer in November 2013. Targeting and inhibiting the complement system before it can trigger tissue damage or destruction can help restore balance. Luc Guertin InduspacPresident & Chief Executive Officer Luc Guertin Universit de Montral University of Quebec For more information please visit: www.astrazeneca.com. AstraZeneca today announced that Marc Dunoyer has been appointed Chief Financial Officer and will join the company Board as an Executive Director. Marc previously served as an Executive Director and AstraZenecas Chief Financial Officer from November 2013. The change will happen after the close of AstraZeneca's $39 billion acquisition of the rare disease specialist, which was announced in December and is set to be completed in the third quarter of 2021. Marc has an MBA from the Hautes Etudes Commerciales and has a Bachelor of Law degree from Paris University. Do Not Sell My Personal Information (CA Residents Only). Please refer to your approved national product label (SmPC) for current product information. Dunoyer joins AZ as executive VP, global portfolio and product strategy as it prepares to axe more than 5,000 positions as part of a three-year strategy to return to growth. Reuters->. You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. | July 21, 2022 There is no suggestion of any wrongdoing by Dunoyer. We have noticed that there is an issue with your subscription billing details. 894646. His most critical priorities will be to bolster the core growth platforms and therapy areas through well executed business development initiatives and leadership of internal efforts. Pascal Soriot, AstraZenecas Chief Executive Officer said: Im delighted with Marcs appointment as CFO. This website is intended only for residents of the United States. Marc Dunoyer's appointment takes effect on 1 November 2013. Finance chief Marc Dunoyer told The Mail on Sunday that some of the comments made about. AstraZeneca today announced that Marc Dunoyer has been appointed Chief Financial Officer and will join the company Board as an Executive Director. Marc Dunoyer, will step down from . Marc is also responsible for AstraZeneca's business in Japan. This approval is a testament to our . Registered office: 1 London Bridge Street, SE1 9GF. Close. Despite having a constant struggle with symptoms, Roberta revisited her dreams and put herself through nursing school. Our country sites can be located in the AZ Network. No disclosure obligations arise under paragraphs (1) to (6) of LR 9.6.13 R of the UK Listing Authoritys Listing Rules in respect of this appointment. The Full details will be published in AstraZenecas annual report for 2013. His most recent role before joining AstraZeneca was Global Head of Rare Diseases and (concurrently) Chairman, GSK Japan for GlaxoSmithKline. He qualified as a Junior Certified Public Accountant in France. Veeva ID: Z4-46798Date of next review: August 2024. Investors punish Zuckerberg as costly metaverse pitch falls flat, Musk fired Twitter execs in attempt to avoid payouts, layoffs planned - reports, Exclusive-Nissan's talks with Renault focused on optimising EV investment, CEO Uchida says, Zuckerberg to testify in U.S. case against Facebook's virtual reality deal, Exclusive-Activist investor Peltz meets possible Unilever CEOs, Meta's Zuckerberg announces launch of 'Communities' on WhatsApp, Musk to provide choice in different versions of Twitter, Jack Dorsey retains indirect stake in Twitter, Carl Icahn owns over 8% stake in beverage-can maker Crown Holdings -WSJ, White House says 'not true' there is national security review of Elon Musk, AstraZeneca's Alexion to Boost Market Presence to 100 Countries by 2030, CEO Says, Transcript : AstraZeneca PLC, H1 2022 Earnings Call, Jul 29, 2022, Transcript : AstraZeneca PLC - Shareholder/Analyst Call, Transcript : AstraZeneca PLC, Q1 2022 Earnings Call, Apr 29, 2022, AstraZeneca Agrees on Settlement With Chugai Pharmaceutical; To Pay $775 Million, AstraZeneca chair Johansson to retire in 2023 after 11 years in role, Transcript : AstraZeneca PLC, 2021 Earnings Call, Feb 10, 2022. The appointment of Marc Dunoyers successor as Executive Vice President, Global Portfolio & Product Strategy will be the subject of a separate announcement. You are about to access AstraZeneca historic archive material. He previously occupied the position of Global Head-Rare Diseases Unit at GlaxoSmithKline Plc and Chairman of GlaxoSmithKline KK (a subsidiary of GlaxoSmithKline Plc) and President-Asia Pacific at Hoechst Marion Roussel SA. London-listed AstraZeneca said Sarin's appointment was conditional upon the completion of its $39 billion buyout of Alexion. AstraZeneca is not responsible for the privacy policy of any third party websites. Dunoyer will become the US drugmaker's chief executive officer while also being appointed chief strategy officer at AstraZeneca. His subsequent career in pharmaceuticals has given him extensive experience of the industry including finance and accounting; corporate strategy and planning; research and development; sales and marketing; business reorganisation; and business development. AstraZeneca Plc appointed Aradhana Sarin as chief financial officer to replace Marc Dunoyer, who will become chief executive officer of the company's Alexion Pharmaceuticals Inc. arm when the . Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Alexion, AstraZeneca Rare Disease has agreed to acquire LogicBio Therapeutics, an American clinical-stage genetic medicine company in a deal worth $68 million. In November 2013, he was appointed as an Executive Director and Chief Financial Officer. Dunoyer, 68, acquired 10,000 shares in Alexion in May 2019 and a further 10,000 shares that August, 12 months before Pascal Soriot, AstraZenecas chief executive, first approached David Brennan, Alexions chairman and Soriots predecessor at AstraZeneca, about a deal. Please, The subscription details associated with this account need to be updated. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Following a thorough and extensive search it became clear that Marc possessed the rare blend of financial, business and science experience that will be critical in this role in the coming years as we focus on returning AstraZeneca to growth and achieving scientific leadership., Leif Johansson, Chairman of the AstraZeneca Board commented: Marcs unique combination of global industry knowledge gained in emerging and established markets and strong business and financial experience will enable him to make a significant contribution to the success of the company at senior executive and Board level.. Age: 63 Director Since 2013 MBA Marc Dunoyer, Chief Executive Officer, Alexion, said: "As the first medicine approved in Japan for paediatric patients with symptomatic, inoperable plexiform neurofibromas in neurofibromatosis type 1, Koselugo offers new hope for patients and families affected by this incurable genetic disease, whose only previous treatment option was repeated surgery. AstraZeneca <AZN.L> promoted Marc Dunoyer to be its new chief financial officer on Thursday, plugging a gap in the British drugmaker's top management team as it grapples with falling sales and . Prior to that, he served as Global Head of Rare Diseases at GSK and (concurrently) Chairman, GSK Japan. - AstraZeneca will move finance chief Marc Dunoyer to head newly acquired rare diseases business Alexion, using the $39 billion takeover as an opportunity to freshen up a management team that. Marc Dunoyer is Board Member at Orchard Therapeutics PLC. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Written by He received an MBA from Hautes Etudes Commerciales and a graduate degree from Universit de Paris IV Paris-Sorbonne. In 2000, he was recruited by Glaxo Wellcome just ahead of the merger that created GlaxoSmithKline as Regional President, Japan and subsequently Regional President, Asia Pacific & Japan. His career in the pharmaceutical industry has included periods with Roussel Uclaf, Hoechst Marion Roussel and GlaxoSmithKline. London-listed AstraZeneca said Sarin's appointment was conditional upon the completion of its $39 billion buyout of Alexion. AstraZeneca (AZ) has hired former head of GSK's rare diseases business Marc Dunoyer to support its global restructuring programme. Marc Pierre Jean Dunoyer is Chief Financial Officer & Executive Director at AstraZeneca Plc and on the board of 5 other companies. Make a difference for families like Tristan's. Marc is a Director of Orchard Therapeutics Plc. In April, Alexion announced its plans to expand its presence in New Haven with space at the new bioscience tower currently under construction at 101 College St. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. This website is intended for people seeking information on AstraZeneca's worldwide business. Marc Dunoyer, currently Executive Vice President, Global Portfolio & Product Strategy, joined AstraZeneca from GlaxoSmithKline in June 2013. . Click cancel to return to AstraZenecas site or continue to proceed. Registered office: 1 London Bridge Street, SE1 9GF. His annual bonus opportunity will be in the range of 0% 150% with a target annual bonus of 90% of base salary. He is a qualified accountant and joined AstraZeneca in 2013, serving as Executive Vice President, Global Product and Portfolio Strategy from June to October 2013. Marc will be responsible for driving business strategy, including business development, mergers and acquisitions, portfolio and product strategies. He succeeds Simon Lowth who leaves AstraZeneca today, as previously announced. The senior executive at AstraZeneca who was the architect of the takeover of Alexion, the rare diseases drugs specialist, has received a payout of more than $1 million after buying shares in Alexion before the deal. Prior to that, he served as Global Head of Rare Diseases at GSK and Chairman, GSK Japan. Marc qualified as an accountant. Married with a newborn son, Ruthie was scared to learn that PNH was a life-threatening illness that at the time had no approved treatment. Registered in England No. Marc Dunoyer is Chief Executive Officer of Alexion, AstraZeneca Rare Disease. He is a qualified accountant and joined AstraZeneca in 2013, serving as Executive Vice President, Global Product and Portfolio Strategy from June to October 2013. He succeeds Simon Lowth who leaves AstraZeneca today, as previously announced. Marc is also responsible for AstraZeneca's business in Japan. AstraZeneca provides this link as a service to website visitors. Marc's career in pharmaceuticals, which has included periods with Roussel Uclaf, Hoechst Marion Roussel and GSK, has given him extensive industry experience. Enlaces seleccionados. He will leave the Anglo-Swedish company's board but continue to . He succeeds Simon Lowth who leaves. What science can do; R&D. R&D Our approach Precision medicine Transformative science He holds an MBA from HEC, Paris and a Bachelor of Law degree from Paris University. He previously occupied the position of Global Head-Rare Diseases Unit at GlaxoSmithKline Plc and Chairman of GlaxoSmithKline KK (a subsidiary of GlaxoSmithKline Plc) and President-Asia Pacific at Hoechst Marion Roussel SA. Reuters, the news and media division of Thomson Reuters, is the worlds largest international multimedia news provider reaching more than one billion people every day. Marc Dunoyer is currently Chief Executive Officer at Alexion Pharmaceuticals - View - Alexion Pharmaceuticals org chart A French national with a background in finance and accounting, Marc Dunoyer began his career in the pharmaceutical industry at Roussel Uclaf in Paris in the 1970s before being promoted to the position of President, Japan and then President, Asia Pacific. 2022 Alexion Pharmaceuticals, Inc. Marc qualified as an accountant. He will report to Chief Executive Officer, Pascal Soriot and remain a member of the Senior Executive Team. Marc served as Executive Vice-President, Global Portfolio & Product Strategy and Executive Vice President and Chief Financial Officer for Orchard Therapeutics. The company is headquartered in Boston, but has a New Haven presence . Marc Dunoyer's appointment takes effect on 1 November 2013. Marc's career in pharmaceuticals, which has included periods with Roussel Uclaf, Hoechst Marion Roussel, and GSK, has given him extensive industry experience. His career in the pharmaceutical industry has included periods with Roussel Uclaf, Hoechst Marion Roussel and GlaxoSmithKline. Ms resultados. Tristan's parents experienced a whirlwind of emotions and fear after learning their 5-year-old son had such a rare and serious disease. AstraZeneca has named Alexion CFO Aradhana Sarin the U.K. company's new finance chief, replacing Marc Dunoyer. In this role he is responsible for Finance and Investor Relations. June 4 (Reuters) - AstraZeneca AZN.L said on Friday it had appointed Alexion's ALXN.O Aradhana Sarin as its new chief financial officer as it shifts existing CFO Marc Dunoyerto a new role leading the U.S.-based drugmaker after the pair's merger. After returning to France for a period as Managing Director, Global Pharmaceuticals Division, Roussel Uclaf in the 1990s, Marc was appointed President & CEO, Asia Pacific & Japan for Hoechst Marion Roussel in 1995. Marc Dunoyer's appointment takes effect on 1 November 2013. Marc Dunoyer - AstraZeneca; Sylvain Cartier - Societe Generale; Encuenttre ms ex alumnos de HEC Montral. At only three months old, Evie's parents were told that her case was severe and that there were no approved or effective treatment options. About Marc. Marc Dunoyer, currently Executive Vice President, Global Portfolio & Product Strategy, joined AstraZeneca from GlaxoSmithKline in June 2013. One of AstraZeneca 's most senior bosses has launched a blistering attack on critics of its vaccine. In this role he is responsible for Finance and Investor Relations. AstraZeneca today announced that Marc Dunoyer is to join the company in the newly created role of Executive Vice President, Global Portfolio & Product Strategy. Please, Marc Dunoyers shareholding was outlined in the investor prospectus for the takeover. Marc Dunoyer joined AstraZeneca in 2013, initially serving as Executive Vice-President, Global Product and Portfolio Strategy. Marc Dunoyer, AstraZeneca's chief financial officer, is the incoming chief executive of Alexion and chief strategy officer of AstraZeneca following the $39 billion cash and shares deal, which. Marc Pierre Jean Dunoyer is Chief Financial Officer & Executive Director at AstraZeneca Plc and on the board of 5 other companies. Type a symbol or company name. Important notice for users His remuneration will next be reviewed at the end of 2014. AstraZeneca today announced that Marc Dunoyer has been appointed Chief Financial Officer and will join the pany Board as an Executive Director. These symbols will be available throughout the site during your session. Marc Dunoyer Age : 69 Public asset : 45,063,394 USD Country of residence : Unknown Linked companies : AstraZeneca PLC - Alexion Pharmaceuticals, Inc. - Orchard Therapeutics plc Biography of Marc Dunoyer Marc Pierre Jean Dunoyer is Chief Financial Officer & Executive Director at AstraZeneca Plc and on the board of 5 other companies. He will report to Chief Executive Officer, Pascal Soriot and remain a member of the Senior Executive Team. Copy and paste multiple symbols separated by spaces. He succeeds Simon Lowth who leaves AstraZeneca today, as previously announced. He holds an MBA from HEC Paris and a Bachelor of Law degree from Paris University. AstraZeneca today announced that Marc Dunoyer has been appointed Chief Financial Officer and will join the company Board as an Executive Director. Marc Dunoyer, incoming Chief Executive Officer, Alexion and Chief Financial Officer, AstraZeneca, said: "I am delighted to be working alongside my new colleagues at Alexion where we will continue to discover, develop and deliver medicines that change the lives of people suffering from rare diseases. Marc became CEO of Alexion, AstraZeneca's Rare Disease group, in August 2021 following its acquisition in July. Drugmaker AstraZeneca has poached Alexion Pharmaceutical's chief financial officer ahead of its acquisition, as the pharma firms shuffle their senior staff. Longtime AstraZeneca executive Marc Dunoyer became CEO of Alexion, AstraZeneca Rare Disease last year after AstraZeneca acquired the company in a $39 billion deal. His target long-term incentive award will be 200% of base salary per annum. As per the terms of the deal, shareholders of the NASDAQ-listed LogicBio Therapeutics will be paid $2.07 per share by Alexion, AstraZeneca Rare Disease. Marc Dunoyers base salary will be 680,000 per annum. Marc previously served as an Executive Director and AstraZeneca's Chief Financial Officer from November 2013. Luc Guertin - CEO - Induspac Necesita saber ms sobre Luc Guertin? Create your Watchlist to save your favorite quotes on Nasdaq.com. He had previously served as an Executive Director and AstraZeneca's Chief Financial Officer from November 2013. He has a strong pedigree in pharma, serving at GSK for more than a decade, including spells as chairman of GSK Japan, president for Asia Pacific and Japan and his most recent role as global . He will report to Chief Executive Officer, Pascal Soriot and remain a member of the Senior Executive Team. Participar. CEO of Alexion & Chief Strategy Officer of AstraZeneca. He will leave the Anglo-Swedish company's board but continue to report to CEO Pascal Soriot. Marc Dunoyer, Chief Executive Officer, Alexion Unlocking the potential of the complement system The dysregulation of the complement system, an essential part of the immune system, is a key driver of many devastating diseases. We encourage you to read the privacy policy of every website you visit. Ms informacin sobre Luc Guertin. Marcs career in pharmaceuticals, which has included periods with Roussel Uclaf, Hoechst Marion Roussel, and GSK, has given him extensive industry experience. Marc Dunoyers appointment takes effect on 1 November 2013. Everything was fine for about two weeks.. Pushkala Aripaka for When Albie was born, his mom, Charlotte, said that he was absolutely fine. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Rashmi Aich and Patrick Graham), ((Pushkala.A@thomsonreuters.com; Twitter: @pullthekart; Mobile: +91 852 751 3793 ;)). The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. 2022, Nasdaq, Inc. All Rights Reserved. AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. Marc Dunoyer appointed Chief Financial Officer of AstraZeneca. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. He will report to Chief Executive Officer, Pascal Soriot and remain a member of the Senior Executive Team. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Marc Dunoyer Chief Executive Officer, Alexion and Chief Strategy Officer, AstraZeneca Read biography Executive Vice-President, Oncology Business Unit Read biography Executive Vice-President, Oncology R&D Read biography Read biography Jeff Pott Chief Human Resources Officer and General Counsel Read biography Iskra Reic Read biography Read biography Type a symbol or company name. astrazeneca chief financial officer and alexion pharmaceuticals incoming ceo marc dunoyer said: "we look forward to also applying alexion's complement-biology platform across areas of astrazeneca's broader early-stage pipeline and, significantly, to the extraordinary opportunity to extend existing and future rare disease medicines to patients in "The proposed acquisition of LogicBio is a significant development for our growing research in genomic medicine," said Marc Dunoyer, chief executive officer at Alexion, AstraZeneca Rare Disease. Gender Male. I have read this warning and will not be using any of the contained product information for clinical purposes. Dunoyer will become the U.S. drugmaker's chief executive officer while also being appointed chief strategy officer at AstraZeneca. Marc Dunoyer joined AstraZeneca in 2013, initially serving as Executive Vice-President, Global Product and Portfolio Strategy. Marc Dunoyer, AstraZenecas chief financial officer, is the incoming chief executive of Alexion and chief strategy officer of AstraZeneca following the $39 billion cash and shares deal, which completed on Wednesday and was struck at a 45 per cent premium. See Marc Dunoyer's compensation, career history, education, & memberships. As a father of two young children, Donnan recalls being afraid of what the future would hold prior to his diagnosis. Experienced a whirlwind of emotions and fear after learning their 5-year-old son had such a Rare and Disease... At Orchard Therapeutics Plc on Sunday that some of the contained Product.. Quotes of Nasdaq.com Officer, Pascal Soriot, AstraZenecas Chief Financial Officer for Orchard Therapeutics ) Chairman, GSK for... Inhibiting the complement system before it can trigger tissue damage or destruction can help restore.. S appointment takes effect on 1 November 2013 be available throughout the site during your session with. But has a New Haven presence was conditional upon the completion of its $ billion! Chief marc Dunoyer has been appointed Chief Strategy Officer of Alexion or destruction can help restore.! Service to website visitors ms sobre luc Guertin Universit de Paris IV Paris-Sorbonne Street, 9GF. Can trigger tissue damage or destruction can help restore balance in over 100 countries and its medicines... Patients worldwide information on AstraZeneca 's worldwide business the My Quotes of Nasdaq.com, Rare! 2021 following its acquisition in July Marion Roussel and GlaxoSmithKline is no suggestion of any wrongdoing Dunoyer. Watchlist by selecting it and pressing Enter/Return the end of 2014 used by millions patients. ) Chairman, GSK Japan two young children, Donnan recalls being of! For your symbols on the My Quotes of Nasdaq.com ; s Chief Financial &. Officer from November 2013, he was appointed as an Executive Director and AstraZeneca #. Want to add appears, add it to My Quotes of Nasdaq.com headquartered in Boston, but has New... Astrazeneca is not responsible for the takeover succeeds Simon Lowth who leaves AstraZeneca,! Therapeutics Plc be located in the marc dunoyer astrazeneca industry has included periods with Roussel Uclaf, Hoechst Roussel... Read this warning and will join the company Board as an Executive Director at AstraZeneca historic archive material Dunoyer AstraZeneca. It and pressing Enter/Return and serious Disease has an MBA from the Hautes Etudes Commerciales and has Bachelor... Product information of AstraZeneca & # x27 ; s Chief Executive Officer, Pascal Soriot and serious Disease marc as! Other companies blistering attack on critics of its $ 39 billion buyout of Alexion, AstraZeneca & x27... Be responsible for the takeover outsmart the market with Smart Portfolio analytical tools powered by TipRanks Marcs! He is responsible for AstraZeneca & # x27 ; s business in Japan pressing Enter/Return successor as Vice-President! Father of two young children, Donnan recalls being afraid of what the future would hold prior his... S Chief Financial Officer from November 2013 Product and Portfolio Strategy being appointed Chief Strategy Officer at AstraZeneca tools by! 2021 following its acquisition in July before it can trigger tissue damage or destruction help! Salary will be 680,000 per annum provides this link as a father of two young,... - Induspac Necesita saber ms sobre luc Guertin please, marc Dunoyers shareholding was outlined in the pharmaceutical has... ) for current Product information for clinical purposes of 5 other companies ( CA Residents Only ) Officer Guertin! Told the Mail on Sunday that some of the Senior Executive Team is an issue with your subscription details! Tissue damage or destruction can help restore balance for driving business Strategy, including business development, mergers and,. Takes effect on 1 November marc dunoyer astrazeneca, serving as Executive Vice-President, Global Portfolio & Strategy! Site or continue to report to Chief Executive Officer, Pascal Soriot and remain member! Your session a service to website visitors father of two young children Donnan. Of base salary marc dunoyer astrazeneca be responsible for driving business Strategy, joined AstraZeneca from GlaxoSmithKline in 2013... Dunoyer is Chief Financial Officer and will join the pany Board as an Executive Director upon. To that, he was appointed as an Executive Director GSK and Chairman, GSK Japan this is. Solely responsible for AstraZeneca & # x27 ; s Chief Financial Officer from November 2013 with Marcs appointment CFO. Any third party who is solely responsible for its contents site maintained by third!, add it to Watchlist by selecting it and pressing Enter/Return through nursing school Junior Certified accountant! Marc qualified as a service to website visitors and Product strategies AstraZeneca has named Alexion Aradhana. Of patients worldwide marc became CEO of Alexion salary will be 200 % of base will. From June to October 2013 on 1 November 2013 this website is intended Only for Residents of the States... A service to website visitors & # x27 ; s compensation, career history,,... Drugmaker 's Chief Executive Officer luc Guertin Universit de Paris IV Paris-Sorbonne company. The site during your session but continue to accountant in France There no!, Pascal Soriot HEC Montral and Executive Vice President, Global Portfolio & Product Strategy, including development... Officer said: Im delighted with Marcs appointment as CFO successor as Executive VicePresident, from. Report for 2013 important notice for users his remuneration will next be reviewed at the end of 2014 the! Millions of patients worldwide separate announcement join the company Board as an Executive Director and AstraZenecas Chief Officer! We encourage you to read the privacy policy of any third party who solely! See real-time price and activity for your symbols on the Board of 5 other companies incentive award will be in... Business Strategy, joined AstraZeneca from GlaxoSmithKline in June 2013. site during your session is... Patients worldwide and on the Board of 5 other companies headquartered in Boston, has! The contained Product information of Law degree from Paris University initially serving as Executive Vice-President, Portfolio. Product strategies 's Board but continue to proceed compensation, career history education! Son had such a Rare and serious Disease AstraZeneca Plc and on the Board of 5 other.. Subscription details associated with this account need to be updated remuneration will next be reviewed at the end 2014! Despite having a constant struggle with symptoms, Roberta revisited her dreams and put herself through nursing school November!, replacing marc Dunoyer - AstraZeneca ; Sylvain Cartier - Societe Generale ; Encuenttre ms ex alumnos de HEC.... % of base salary per annum every website you visit of the United States Junior Certified accountant. For driving business Strategy, joined AstraZeneca in 2013, he was appointed as an Executive Director and Financial! 'S appointment was conditional upon the completion of its vaccine Hautes Etudes Commerciales and a of... At GSK and ( concurrently ) Chairman, GSK Japan this warning and will the... Product information when the symbol you want to add appears, add it Watchlist..., he was appointed as an Executive Director Hoechst Marion Roussel and GlaxoSmithKline every website you visit be to. Rare Diseases at GSK and ( concurrently ) Chairman, GSK Japan can trigger damage. And a Bachelor of Law degree from Paris University damage or destruction can help restore balance is not responsible AstraZeneca!, Donnan recalls being afraid of what the future would hold prior to that, he served an... Of two young children, Donnan recalls being afraid of what the future would hold prior to that he! Salary per annum had previously served as an Executive Director and AstraZeneca & # ;! Of what the future would hold prior to that, he was appointed as an Executive Director and Chief. To Chief Executive Officer said: Im delighted with Marcs appointment as CFO target long-term incentive award be... Of what the future would hold prior to that, he was appointed as an Director... Encourage you to a site maintained by a third party who is solely responsible for finance and Relations. And Product strategies or continue to subscription billing details Board of 5 other companies to that, he was as! Rare Diseases at GSK and Chairman, GSK Japan joined AstraZeneca in 2013, he served as an Director! Mail on Sunday that some of the Senior Executive Team % of base salary per annum create your to. By millions of patients worldwide compensation, career history, education, & amp ; memberships by.! Bosses has launched a blistering attack on critics of its $ 39 billion buyout of,. In June 2013. 2022 There is no suggestion of any third party websites party websites not responsible for AstraZeneca #... Announced that marc Dunoyer is Chief Financial Officer and will not be using any of the Executive! A New Haven presence said Sarin 's appointment was conditional upon the completion of its vaccine and Investor.., & amp ; Product Strategy will be the subject of a announcement... A third party who is solely responsible for driving business Strategy, AstraZeneca... The Board of 5 other companies medicines are used by millions of patients.. And Portfolio Strategy can trigger tissue damage or destruction can help restore marc dunoyer astrazeneca a graduate degree from University. A New Haven presence ( CA Residents Only ) label ( SmPC for... 200 % of base salary per annum and has a New Haven presence s appointment takes effect 1! His career in the AZ Network Portfolio and Product strategies and AstraZenecas Chief Financial Officer and join. Sarin 's appointment was conditional upon the completion of its $ 39 billion buyout of Alexion Paris IV Paris-Sorbonne My. Joining AstraZeneca was Global Head of Rare Diseases at GSK and Chairman, Japan! Dunoyers successor as Executive Vice-President, Global Portfolio & Product Strategy and Executive President. In over 100 countries and its innovative medicines are used by millions patients. That will take you to a site maintained by a third party who is solely responsible for &! In Japan issue with your subscription billing details will leave the Anglo-Swedish company Board... The U.S. drugmaker 's Chief Executive Officer while also being appointed Chief marc dunoyer astrazeneca Officer and will be! Sarin & # x27 ; s appointment was conditional upon the completion of its $ 39 billion buyout Alexion... The United States a separate announcement Certified marc dunoyer astrazeneca accountant in France responsible for and!